DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD
(NASDAQ: DBVT)

DBV Technologies SA is a France-based company focused on the development of products for the diagnosis and treatment of food allergies. The Company�s products are designed to deliver on intact skin allergens against food allergies and for allergy diagnosis. The antigens (allergens) are delivered to the skin using DBV Technologies� system, Viaskin, a non-invasive delivery system that utilizes electrostatic forces to present and deliver active compounds to the epidermis of the skin, without breaking the basement membrane (blood-skin barrier). Its product portfolio for allergy treatments consists of Viaskin, Viaskin Peanut, Viaskin Milk and for allergy diagnosis Diallertest Milk for the diagnosis of cow�s milk allergy in children. In April 2014, it established a new subsidiary, DBV Technologies Inc.

0.749

-0.018 (-2.35%)
价格区间 0.720 - 0.760   (5.56%)
开盘 0.732
昨收 0.767
1.830
买盘 30
1.850
卖盘 13
成交量 14,556
成交额 -
注释
数据延迟。最后一次更新28 Mar 2024 00:00.
数据提供商
查看所有活动

关于 DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD

DBV Technologies SA is a France-based company focused on the development of products for the diagnosis and treatment of food allergies. The Company�s products are designed to deliver on intact skin allergens against food allergies and for allergy diagnosis. The antigens (allergens) are delivered to the skin using DBV Technologies� system, Viaskin, a non-invasive delivery system that utilizes electrostatic forces to present and deliver active compounds to the epidermis of the skin, without breaking the basement membrane (blood-skin barrier). Its product portfolio for allergy treatments consists of Viaskin, Viaskin Peanut, Viaskin Milk and for allergy diagnosis Diallertest Milk for the diagnosis of cow�s milk allergy in children. In April 2014, it established a new subsidiary, DBV Technologies Inc.

Loading Chart...

Please login to view stock data and analysis